| advertise add site services publishers database health videos | ![]() | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Amylin Pharmaceuticals (NASDAQ: AMLN): Upgraded To Overweight At Barclays ...istockAnalyst.com (press release) - 1 hour ago Barclays is upgrading Amylin Pharmaceuticals (NASDAQ:AMLN) to Overweight from Equal-Weight with a $22 price target (prev. $16). According to the firm, ... HP: Analysts' Upgrades, DowngradesTheStreet.com - 1 hour ago By TSC Staff 11/24/09 - 09:24 AM EST Amylin Pharmaceuticals (AMLN Quote) upgraded at Barclays to Overweight from Equal Weight. Price target lifted to $22 ... Upgrades & Downgrades: Tiffany's Time to ShineMinyanville.com - 1 hour ago Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop ...Reuters - Nov 1, 2009 About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, ... Amylin signs weight-loss drug deal with Takeda The Associated Press Pharma's big movers: Amylin up on obesity drug, Hep C drug lifts Vertex Daily Finance (blog) REG-Lilly (Eli) & Co: STATEMENT ON FDA'S BYETTA (EXENATIDE) INJECTION UPDATEReuters - Nov 2, 2009 About Amylin and Lilly Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and ... Amylin Scores a Hat Trick Motley Fool CORRECT:=FDA Approves New Byetta Label Amid Renal-Failure Reports Wall Street Journal Byetta gets new indication, new warnings FiercePharma Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare ...Reuters - Nov 5, 2009 Mark Foletta, senior vice president of finance and chief financial officer at Amylin Pharmaceuticals, will be providing a corporate overview. ... Top Day Trader Alerts (AMLN, BRCD, TIVO, SEED, FEED)24/7 Wall St. (blog) - 1 hour ago US HOT STOCKS: Analog Devices, Medtronic, Barnes & NobleWall Street Journal - 7 minutes ago Orexigen Therapeutics Appoints Dawn Viveash As Head Of Global Regulatory ...RTT News - 22 hours ago Viveash was most recently at Amylin Pharmaceuticals as Vice President of Regulatory Affairs and Safety The company also appointed Suzanne McDonald as Head ... Four Senior Executives Join Orexigen(R) Therapeutics Management Team PR Newswire (press release) Home sales surge thanks to tax incentive for new buyers San Diego Union Tribune Global effort intensifies to tackle diabetes epidemicSan Diego Daily Transcript (subscription) - - Nov 20, 2009 That global effort has combined a San Diego company, Amylin Pharmaceuticals, with Takeda Pharmaceutical in Japan to develop and commercialize products for ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests... Bernard von NotHaus (Liberty Dollar) Aubrey de Grey, PhD Dr. Amanuel Sima, MD Dr. Bard Levey, DDS Neal Adams Robin Scovill (director) Richard Diaz (author) Dr. Kaayla T. Daniel, CCN Chana de Wolf, (cryonics researcher) Dr. Mary Ruwart (author & scientist) Richard Diaz (author) Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |